DealBio
All collections

Investor Intelligence

10 Healthcare AI Investors in Europe

Investors backing European healthcare AI across clinical software, medical imaging, diagnostics and healthcare data infrastructure.

Published
  • Healthcare AI
  • Digital Health
  • Medical Imaging
  • Europe
  • Seed
  • Series A

in Europe is drawing capital from specialist health investors, technology funds and strategic healthcare groups. The investable market now spans , imaging infrastructure, genomics interpretation, radiology foundation models and AI-enabled drug development, so relevant investors can enter through several distinct healthcare workflows.

DealBio selected 10 investors with evidenced relevance to healthcare AI in Europe, using current investor research, financing precedents and public verification where needed.

Nina Capital

Specialist venture firm investing exclusively at the intersection of healthcare and information technology.

Stage
Pre-seed · Seed
Sector / Focus
Healthcare AI · Digital health
Investment markets
Spain · Europe
Investor type
VC

Relevant investment

Nina Capital co-led Datamonk’s €1.6 million pre-seed round in October 2025. Datamonk uses agentic AI to automate medical-imaging migrations, repair data-quality issues and prepare hospital imaging data for clinical workflows, research and AI applications, giving Nina a direct healthcare-AI infrastructure precedent.

Healthy.Capital

Healthcare-focused investment firm backing technology intended to improve access, efficiency and outcomes.

Stage
Pre-seed · Seed
Sector / Focus
Digital health · Healthcare AI
Investment markets
The Netherlands · Europe
Investor type
VC

Relevant investment

Healthy.Capital co-led Datamonk’s €1.6 million pre-seed round in October 2025 alongside Nina Capital. The company’s agentic-AI platform automates PACS and VNA migrations and cleans imaging data, linking Healthy.Capital directly to AI infrastructure used inside hospital imaging workflows.

Founders Future

Transatlantic technology investor backing AI-first companies from early stage through growth.

Stage
Seed · Series A
Sector / Focus
AI · Healthcare
Investment markets
France · Europe
Investor type
VC

Relevant investment

Founders Future participated in Raidium’s €16 million seed round announced in November 2024. Raidium is building generative-AI foundation models and an AI-native imaging viewer for radiology, giving the fund direct exposure to clinical imaging AI and precision-radiology infrastructure.

Newfund

Early-stage venture firm investing in technology companies in France and internationally.

Stage
Seed · Series A
Sector / Focus
Healthcare AI · Digital health
Investment markets
France · Europe
Investor type
VC

Relevant investment

Newfund co-led Raidium’s €16 million seed round announced in November 2024. Raidium develops generative-AI foundation models for medical imaging and an AI-native radiology viewer, a direct healthcare-AI precedent rather than general-purpose software.

Galion.exe

French early-stage investment platform backing technology founders.

Stage
Seed · Series A
Sector / Focus
Healthcare AI · Precision medicine
Investment markets
France
Investor type
VC

Relevant investment

Galion.exe participated in Raidium’s €16 million seed financing. Raidium applies generative AI to medical imaging through foundation models and an AI-native viewer designed for radiology workflows, giving Galion.exe direct exposure to healthcare AI deployed around clinical imaging.

Debiopharm

Swiss life-sciences group with investment activity spanning digital health, smart data and therapeutics.

Stage
Seed · Series A
Sector / Focus
Digital health · Smart data · Healthcare AI
Investment markets
Switzerland · Europe
Investor type
Strategic investor

Relevant investment

Debiopharm participated in Raidium’s €16 million seed financing announced in 2024. Raidium is developing AI-native radiology infrastructure and foundation models for medical imaging, adding a healthcare-AI precedent to Debiopharm’s broader life-sciences and digital-health activity.

Antler

Global early-stage investor and company-building platform investing from company formation onward.

Stage
Pre-seed · Seed
Sector / Focus
Healthcare AI · Healthtech
Investment markets
Europe
Investor type
VC / Venture builder

Relevant investment

Antler backed Datamonk, whose agentic-AI platform automates medical-imaging data migrations, repairs data-quality issues and prepares hospital imaging data for clinical and AI workflows. The investment gives Antler a direct healthcare-AI infrastructure precedent.

Springboard Health Angels

Expert angel syndicate focused on early-stage health technology and life sciences.

Stage
Pre-seed · Seed
Sector / Focus
Healthcare AI · Diagnostics
Investment markets
Germany · Europe
Investor type
Angel network

Relevant investment

Springboard Health Angels backed Qnomx, a Basel company using AI for genomic- and clinician-ready oncology diagnostics. The investment gives the angel network direct exposure to healthcare AI used in molecular diagnostics and precision oncology.

LBO France

French investment firm with a dedicated digital-health venture strategy.

Stage
Series A · Growth
Sector / Focus
Healthcare AI · Digital health · Remote monitoring
Investment markets
France · Europe
Investor type
VC / Private markets investor

Relevant investment

LBO France is an existing investor in Incepto Medical and participated again in the company’s €14 million financing announced in September 2026. Incepto operates a European platform for deploying artificial intelligence in medical imaging, giving LBO France direct exposure to AI used in radiology at clinical scale.

Cathay Innovation

Global venture firm investing across AI and technology-enabled industries.

Stage
Series A · Growth
Sector / Focus
Healthcare AI · AI · Precision medicine
Investment markets
France · Europe · Global
Investor type
VC

Relevant investment

Cathay Innovation invested in Owkin’s $11 million Series A and reinvested in later rounds. Owkin uses AI and to support drug discovery, clinical development and precision diagnostics, giving Cathay a long-running healthcare-AI precedent.

Methodology

DealBio builds investor lists using structured investor research, demonstrated investment activity and current public verification where needed. The methodology highlights investors with evidenced relevance to the article’s sector, stage and geography.

Get the DealBio Pulse

Weekly insights on health and longevity startups, standout founders, key markets, and notable exits.

You can unsubscribe at any time.